Excellence in science, leading in methods, professional and independent, efficient organisation
Quality in Pathology
Quality in Pathology QuIP GmbH – is the provider of quality in pathology in Germany. QuIP supports pathologists and pharmaceutical companies, as well as diagnostics providers in comparing and optimising their research results. At the same time, QuIP continually develops methods to enhance knowledge. To this end, QuIP has been offering proficiency tests since 2004. QuIP is a joint venture of the German Society of Pathology (Deutsche Gesellschaft für Pathologie e. V. – DGP) and the Federal Association of German Pathologists (Bundesverband Deutscher Pathologen e.V. – BDP). QuIP is currently preparing for accreditation according to DIN EN ISO 17043.
Excellence in Pathology
We achieve quality in pathology by defining standards for the best possible diagnostic performance in proficiency tests. These standards are always based on the current medical and technical state of knowledge. At the same time, the standards are aligned with transparent procedures and take economic efficiency into account .
Pathology institutes at German universities perform first profiency test.
Immunohistochemical proficiency test “2000” includes an IAP workshop held in Würzburg presenting the results, more than 20 IHC proficiency tests are to follow.
The Federal Association of German Pathologists (Bundesverband Deutscher Pathologen e.V. – BDP) and the German Society of Pathology (Deutsche Gesellschaft für Pathologie e. V. – DGP) found QuIP – Quality in Pathology as a common subsidiary.
Proficiency tests on predictive factors for mammary carcinoma including in-situ-hybridisation (Hannover)
First proficiency test (RAS) in molecular pathology conducted in Munich, followed by numerous molecular proficiency tests.
Cooperation with Reference Institute for Bioanalytics (RfB) launched.
European Society of Pathology (Europäische Gesellschaft für Pathologie - ESP) and QuIP agree on mutually recognising their certificates.
QuIP Ltd. (QuIP GmbH) is founded by BDP and DGP.
More than 30 proficiency tests are conducted, IHC and molecular pathology each account for about 50 percent.
Preparing for digital proficiency tests